Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Franca Centorrino, M.D.

Co-Author

This page shows the publications co-authored by Franca Centorrino and Ross Baldessarini.
Connection Strength

6.217
  1. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Hum Psychopharmacol. 2010 Mar; 25(2):179-86.
    View in: PubMed
    Score: 0.443
  2. Hospital use of antipsychotic drugs: polytherapy. Compr Psychiatry. 2008 Jan-Feb; 49(1):65-9.
    View in: PubMed
    Score: 0.377
  3. Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes (Lond). 2006 Jun; 30(6):1011-6.
    View in: PubMed
    Score: 0.342
  4. Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both. Hum Psychopharmacol. 2006 Apr; 21(3):189-93.
    View in: PubMed
    Score: 0.338
  5. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol. 2005 Oct; 20(7):485-92.
    View in: PubMed
    Score: 0.326
  6. Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol. 2005 Jul; 20(5):355-8.
    View in: PubMed
    Score: 0.321
  7. Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients. J Psychiatr Pract. 2005 Jul; 11(4):241-7.
    View in: PubMed
    Score: 0.321
  8. Ziprasidone: first year experience in a hospital setting. J Psychiatr Pract. 2004 Nov; 10(6):361-7.
    View in: PubMed
    Score: 0.306
  9. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry. 2004 Apr; 161(4):700-6.
    View in: PubMed
    Score: 0.294
  10. Oxcarbazepine: clinical experience with hospitalized psychiatric patients. Bipolar Disord. 2003 Oct; 5(5):370-4.
    View in: PubMed
    Score: 0.284
  11. Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders. Am J Psychiatry. 2003 Jul; 160(7):1348-50.
    View in: PubMed
    Score: 0.279
  12. Delirium during clozapine treatment: incidence and associated risk factors. Pharmacopsychiatry. 2003 Jul; 36(4):156-60.
    View in: PubMed
    Score: 0.279
  13. Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry. 2002 Nov; 159(11):1932-5.
    View in: PubMed
    Score: 0.267
  14. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry. 2002 Jan; 159(1):109-15.
    View in: PubMed
    Score: 0.252
  15. Factors associated with noncompliance with psychiatric outpatient visits. Psychiatr Serv. 2001 Mar; 52(3):378-80.
    View in: PubMed
    Score: 0.238
  16. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. Am J Psychiatry. 1995 Jul; 152(7):1038-44.
    View in: PubMed
    Score: 0.160
  17. Factors associated with length of psychiatric hospitalization. Compr Psychiatry. 2014 Apr; 55(3):681-7.
    View in: PubMed
    Score: 0.143
  18. Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics. Hum Psychopharmacol. 2012 Sep; 27(5):521-6.
    View in: PubMed
    Score: 0.132
  19. Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur Neuropsychopharmacol. 2012 Jun; 22(6):415-8.
    View in: PubMed
    Score: 0.125
  20. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients. Int Clin Psychopharmacol. 2011 Mar; 26(2):88-95.
    View in: PubMed
    Score: 0.119
  21. Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders. Pharmacopsychiatry. 2010 Aug; 43(6):225-32.
    View in: PubMed
    Score: 0.114
  22. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010 Jun; 167(6):686-93.
    View in: PubMed
    Score: 0.111
  23. Comparison of mania patients suitable for treatment trials versus clinical treatment. Hum Psychopharmacol. 2008 Aug; 23(6):447-54.
    View in: PubMed
    Score: 0.099
  24. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry. 2007 Mar; 68(3):380-3.
    View in: PubMed
    Score: 0.090
  25. Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophr Res. 2006 Sep; 86(1-3):251-5.
    View in: PubMed
    Score: 0.086
  26. Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents. CNS Drugs. 2002; 16(4):249-61.
    View in: PubMed
    Score: 0.063
  27. Leukopenia associated with addition of paroxetine to clozapine. J Clin Psychiatry. 1998 Jan; 59(1):31.
    View in: PubMed
    Score: 0.048
  28. Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Saf. 1996 Nov; 15(5):333-46.
    View in: PubMed
    Score: 0.044
  29. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry. 1996 Jun; 153(6):820-2.
    View in: PubMed
    Score: 0.043
  30. Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites. Am J Psychiatry. 1995 Apr; 152(4):610-2.
    View in: PubMed
    Score: 0.039
  31. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol. 1994 Apr; 14(2):119-25.
    View in: PubMed
    Score: 0.037
  32. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry. 1994 Jan; 151(1):123-5.
    View in: PubMed
    Score: 0.036
  33. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology. 1993 Sep; 9(2):117-24.
    View in: PubMed
    Score: 0.035
  34. Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder. Harv Rev Psychiatry. 2002 Sep-Oct; 10(5):255-75.
    View in: PubMed
    Score: 0.016
  35. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography. Clin Chem. 1993 Aug; 39(8):1656-9.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.